Posted by Michael Wonder on 26 Nov 2018
UK pharma industry reacts to outcome of European Council meeting
25 November 2018 - The European Council has endorsed the Agreement on the withdrawal of the UK from the EU and has approved the Political Declaration setting out the framework for the future relationship between the UK and the EU.
Recognising the significance of this development in the Brexit process, Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry (ABPI), said:
“The terms of the deal mean that medicines will continue to reach the patients who need them when the UK leaves the EU in March."
